Location History:
- Pittsburg, CA (US) (2002 - 2006)
- Antioch, CA (US) (1999 - 2013)
- Pitsburg, CA (US) (2013)
Company Filing History:
5 out of 5 
3 out of 7 
1 out of 1 Years Active: 1999-2013
Title: Brian Charles Keller: Innovator in Liposomal Formulations and Nanotechnology
Introduction
Brian Charles Keller is a notable inventor based in Antioch, CA (US), recognized for his contributions to the fields of liposomal formulations and nanotechnology. With a total of 16 patents to his name, Keller has made significant strides in developing innovative solutions for health and environmental challenges.
Latest Patents
One of Keller's latest patents is a liposomal formulation for oral administration of glutathione (reduced). This invention provides a composition that can be administered orally to deliver systemic glutathione, which is crucial for improving symptoms related to glutathione deficiency, such as Parkinson's disease and cystic fibrosis. The formulation also considers compounds that enhance the effects of liposomal glutathione, including Selenium, EDTA, carbidopa, and levodopa. Another significant patent involves the use of diacylglycerol PEGs (DAG-PEGs) for the encapsulation, remediation, and recovery of spilled oil. This innovative approach utilizes DAG-PEGs to encapsulate oil in liposomes, effectively sequestering it from causing environmental damage.
Career Highlights
Throughout his career, Keller has worked with various organizations, including Biozone Laboratories, Inc. His work has focused on creating practical applications of his inventions, particularly in health and environmental sectors.
Collaborations
Keller has collaborated with professionals such as Alenka Lasic, a legal representative, and F Timothy Guilford, contributing to the development and protection of his innovative ideas.
Conclusion
Brian Charles Keller stands out as an influential inventor whose work in liposomal formulations and nanotechnology has the potential to make a significant impact on health and environmental remediation. His innovative patents reflect a commitment to addressing critical challenges through scientific advancement.